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RESUMO.- [Ocorrência de anticorpos anti-Neospora
caninum e anti-Toxoplasma gondii em cães com leish-
maniose visceral.] A presença de anticorpos anti-Neos-
pora caninum e anti-Toxoplasma gondii foi avaliada em
cães não infectados e naturalmente infectados com Leish-
mania chagasi manifestando diferentes formas clínicas da
enfermidade. Amostras de sangue foram coletadas de 110
cães sem raça definida. Os soros foram avaliados por meio
da reação de imunofluorescência indireta (RIFI) e os ani-
mais com leishmaniose visceral (LV) (n=60) foram classi-
ficados clinicamente. Dos 110 soros analisados, 5 (4,5%)
foram reativos para N. caninum (RIFI≥50) e 36 (32,7%)
para T. gondii (RIFI≥16). Os títulos de anticorpos anti-L.
chagasi em cães assintomáticos (n=10) foram significati-
vamente (P<0,05) mais baixos que aqueles verificados em
oligossintomáticos (n=22), que por sua vez foram signifi-
cativamente menores (P<0,05) que em cães sintomáticos
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(n=28). Não foi observada associação entre infecções por
Leishmania e N. caninum. Entre os cães infectados com
L. chagasi, verificou-se uma tendência de associação
(P=0.053) entre infecção com T. gondii e aparecimento de
sinais clínicos da LV, o que sugere que a manifestação
clínica da LV em cães pode aumentar sua susceptibilida-
de ao T. gondii. A provável influência do quadro de imu-
nossupressão em diferentes formas clínicas da leishmani-
ose canina é abordada.
TERMOS DE INDEXAÇÃO: Leishmaniose visceral canina,
Leishmania chagasi, Toxoplasma gondii, Neospora caninum,
co-infecção, formas clínicas.
INTRODUCTION
Leishmaniasis is a group of illnesses transmitted by sand
flies that affects domestic and wild animals, as well as
humans. Dogs are considered the main reservoir of the
etiological agent of visceral leishmaniasis (VL) in the urban
context and one of the targets in the control strategy. The
clinical characteristics of canine visceral leishmaniasis
(CVL) vary from animals that are apparently healthy to ani-
mals with severe disease (Blavier et al. 2001), with invol-
vement of multiple organs and a wide variety of cutaneous
lesions (Slappendel 1988, Ferrer 1992).
With the emergence of foci of the disease in urban areas,
VL has assumed an important role in public health in many
regions around the world (Marzochi et al. 1994). In the last
several years, the number of human and canine cases of
VL in the metropolitan region of Belo Horizonte, Minas Ge-
rais, Brazil, has increased. In addition to the great lethality
of disease if left untreated, Leishmania infantum (= L.chagasi),
the agent of VL, is capable of modulating lymphocyte
function, causing severe immunosuppression in the host
(Carvalho et al. 1981, Sacks et al. 1987, Pinelli et al. 1994,
Reis et al. 2006a). The compromised immune system can
facilitate the infection, proliferation and spread of the
pathogens after the initial infection and can allow the emer-
gence of latent infection by opportunistic agents. Since the
first case of co-infection of human immunodeficiency virus
(HIV) and leishmaniasis, studies have demonstrated that
this association increases the replication of HIV, as much in
vitro as in vivo (Olivier et al. 2003), and consequently
accelerates the course of infection by HIV (WHO 1997,
Wolday et al. 1999, Cruz et al. 2006).
In VL, as well as in all parasitic diseases, specific factors
found in the host and the parasite determines the develop-
ment of pathogenic lesions and, consequently, the clinical
signs of infection (Noli 1999, Handman 2001). Mancianti et
al. (1988) evaluated dogs naturally infected with L. infantum
in Italy and suggested that these animals could be classi-
fied as asymptomatic, oligosymptomatic or symptomatic.
Neospora caninum and the related parasite Toxoplasma
gondii are cosmopolitan coccidians that cause neurological
disease in dogs, using the dog (McAllister et al. 1998) and
the cat (Dubey & Beattie 1988) as the definitive host, res-
pectively; these animals excrete oocysts in their feces,
contaminating the environment and infecting a wide range
of intermediate hosts.
Co-infection of L. infantum and N. caninum (Cringoli et
al. 1996, Tarantino et al. 2001, Cringoli et al. 2002, Andreotti
et al. 2006) and between these parasites and T. gondii
(Gennari et al. 2006) has been investigated. Some studies
have suggested that the immunosuppression caused by
Leishmania sp. could enhance the susceptibility of dogs to
N. caninum (Cringoli et al. 2002, Gennari et al. 2006).
The clinical signs of parasitic diseases reflect the
interactions of the species or strain with the immune res-
ponse of the host (Pearson 1993). In VL, the dogs manifest
classically distinct clinical forms (Mancianti et al. 1988).
The objective of this study was to analyze the humoral
immune response against N. caninum and T. gondii in dogs
naturally infected with L. chagasi presenting different clinical
conditions, and to compare this with healthy dogs’ immune
response to the same agents.
MATERIALS AND METHODS
Experimental animals
The urban dogs used in this study were captured by the
Zoonosis Control Center in the county of Santa Luzia, in the
metropolitan region of Belo Horizonte, Minas Gerais, Brazil. Sixty
dogs of different breeds, of unknown age and naturally infected
with L. chagasi, were identified during an epidemiological survey
of CVL. The infection and serology diagnoses were confirmed by
indirect immunofluorescence antibody test (IFAT) and enzyme-
linked immunosorbent assay (ELISA). In addition, parasitological
diagnosis was reached by observations of parasite forms in a
cytological examination of bone marrow aspirates. All infected
dogs were clinically classified according to Mancianti et al. (1988)
as follows: asymptomatic dogs - apparently healthy animals;
oligosymptomatic dogs - animals exhibiting lymphoid adeno-
pathy, moderate weight loss and/or dull brittle fur and symptomatic
dogs - animals that exhibited the classical signs of the disease
such as cutaneous alterations (alopecia, exfoliative dermatitis or
ulcers), onicogriphosis, keratoconjunctivitis, cachexia and ane-
mia. Other 50 healthy dogs with negative serological and
parasitological diagnosis tests for L. chagasi, from the same
municipality, also participated of the study as the VL-uninfected
control group.
Serological analysis
Blood samples were obtained by jugular vein puncture
utilizing vacutainer-type tubes, and the serum samples were
stored at -20oC prior to testing. The diagnosis of VL was
conducted through IFAT with a cut-off of 1:40 as described by
Camargo (1974) with modifications. The ELISA was carried out
according to a technique modified from Voller et al. (1979),
using antigen from lysed cultured promastigotes of L. chagasi
strain MHOM/BR/1967/BH46, and rabbit IgG anti-dog antibody
conjugated with horseradish peroxidase. Optical density (OD)
readings were done at 490 nm using a microplate reader (Bio-
Rad 2550, Bio-Rad). The serum cut-off corresponded to the
average OD of eight samples from L. chagasi-negative dogs
from a nonendemic leishmaniasis area added to three stan-
dard deviations.
Anti-N. caninum and anti-T. gondii antibodies were detected
by IFAT based on the studies of Dubey et al. (1988) and
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Camargo (1974), respectively, with cut-off titers of 50 for N.
caninum and 16 for T. gondii. Positive and negative control
sera were included in each slide.  Positive sera were serially
diluted two-fold and tested to establish the maximum reaction
titer.
Statistical analysis
Statistical analyses were conducted using the SPSS
software version 9.0 for Windows. Possible associations
between samples seropositive and seronegative for Leishmania
and the presence of anti-T. gondii and anti-N. caninum antibo-
dies were analyzed using the Fischer test or the Chi-square
test (P≤0.05).  The comparisons between T. gondii and N. cani-
num occurrence in the different VL dog groups were analyzed
by Chi-square test (P≤0.05).
The comparison of Leishmania titer ranks from asympto-
matic, oligosymptomatic and symptomatic dogs was performed
using the Kruskal-Wallis test, with the Mann-Whitney test as a
post-roc test.
RESULTS
The antibody titer values and the clinical category of the dogs
naturally infected with L. chagasi are shown in Table 1. Among
the 60 dogs naturally infected with L. chagasi, 10 (16.7%)
were clinically classified as asymptomatic, 22 (36.7%) as
oligosymptomatic and 28 (46.7%) as symptomatic. The titers
ranged from 80 to 81,920 and the most frequent titer was
20,480 (14/60). There was a significant difference between
Leishmania titer ranks among the three clinical forms (P<0.05).
Titer ranks from asymptomatic animals were lower than
oligosymptomatic titer ranks (P=0.03), which were in turn lower
than symptomatic titer ranks (P=0.03).
Table 2 displays the frequency of different clinical signs
of VL in naturally infected dogs (oligosymptomatic and
symptomatic). Lymphoadenopathy (44/50, 88%) was the
most frequent sign, followed by skin disorders, which
included in decreasing order of frequency, dull fur (40/50,
80%), exfoliative dermatitis (38/50, 76%), hipotricosis/
alopecia (30/50, 60%) and skin ulcers (16/50, 32%).
Ophthalmopathies were observed in 12 of 50 (24%) dogs
and onicogriphosis was observed in 8% (4/50) of the ani-
mals.
Table 3 illustrates the antibody titer values found for N.
caninum and T. gondii. The occurrence of anti-N. caninum
antibodies was 4.5% (1.5%<95% CI<10.3%) with 5 positive
out of 110 dogs, all with titers of 50. For T. gondii, 36 out of
110 dogs (32.7%) had positive results (24.1%<CI
95%<42.3%) and titers ranged from 16 to 4,096, with 128
being the most frequent titer (9/36).
Table 4 presents the occurrence of anti-T. gondii and anti-
N. caninum antibodies in dogs positive and negative for L.
Table 1. IgG antibody titers for Leishmania chagasi as
evaluated by immunofluorescent antibody test in dogs (n=60)
from the municipality of Santa Luzia, Minas Gerais, Brazil
Leishmania chagasi Clinical forms of Leishmaniasis
Titer Number of %   Number of dogs
positive Asympto- Oligosympto- Sympto-
dogs matic matic matic
40 0 0 0 0 0
80 1 1.7 1 0 0
160 5 8.3 2 3 0
320 6 10.0 2 3 1
640 3 5.0 2 1 0
1280 3 5.0 1 1 1
2560 4 6.7 1 2 1
5120 3 5.0 0 0 3
10,240 7 11.7 0 3 4
20,480 14 23.3 1 4 9
40,960 10 16.7 0 5 5
81,920 4 6.7 0 0 4
Total (%) 60 100 10 (16.6) 22 (36.6) 28 (46.6)
Table 2. Frequency of different clinical signs in dogs
(n=50) naturally infected with Leishmania chagasi from
Santa Luzia, Minas Gerais, Brazil
Clinical signs Number Percent with
of dogs symptom
Lymphoadenopathy 44 88
Dull fur 40 80
Exfoliative dermatitis 38 76
Hypotrichosis / Alopecia 30 60
Skin ulcers 16 32
Emaciation 16 32
Nasal hyperkeratosis 12 24
Ophthalmopathies 12 24
Onicogriphosis 4 8
Table 3. IgG antibody titers for Neospora caninum and
Toxoplasma gondii as evaluated by immunofluorescent
antibody test in dogs (n=110) from the municipality of
Santa Luzia, Minas Gerais, Brazil
N. caninum T. gondii
Titer Number Occurrence Titer Number Occurrence
of positive (%) of positive (%)
dogs dogs
50 5 100.0 16 4 11.1
32 3 8.3
64 5 13.9
128 9 25.0
256 5 13.9
512 3 8.3
1,024 5 13.9
4,096 2 5.6
Total 5 4.5 36 32.7
Table 4. Occurrence of antibodies against Neospora
caninum and Toxoplasma gondii in dogs positive (n=60)
and negative (n=50) for Leishmania chagasi from the
municipality of Santa Luzia, Minas Gerais, Brazil
L. chagasi
Positive(%) Negative(%) P value
T. gondii
Positive 15 (25.0) 21 (42.0) 0.058a
Negative 45 (75.0) 29 (58.0)
N. caninum
Positive 2 (3.3) 3 (6.0) 0.657b
Negative 58 (96.7) 47 (94.0)
a Chi-square Test.
b Fisher Test.
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chagasi infection. The occurrence of anti-N. caninum antibo-
dies was 6.0% (3/50) in the L. chagasi-negative group, where-
as in the L. chagasi seropositive group, the occurrence was
3.3% (2/60). No association between Leishmania infection
and presence of anti-N. caninum antibodies was observed
(P=0.657). An occurrence of 42.0% (21/50) and 25.0% (15/
60) of anti-T. gondii antibodies in the seronegative and sero-
positive L. chagasi groups, respectively, was observed. The
statistical analyses showed no significant association between
canine leishmaniasis and T. gondii antibodies. However, when
the presence (oligosymptomatic and symptomatic) or absence
(asymptomatic) of clinical signs in VL dogs were evaluated
(Table 5), a tendency of association was observed with a P
value in the limit of significance (P=0.053, Fisher Test), with
higher occurrence of infection of T. gondii in animals with
symptoms of VL. No significant difference was observed
among T. gondii titer ranks between the oligosymptomatic
and symptomatic groups (P>0.05).
In the VL-infected group, 3.3% (2/60) of the animals
were simultaneously positive for N. caninum and T. gondii,
and in the Leishmania seronegative group, co-infection was
observed in 2.0% (1/50) of the dogs. The proportion test
revealed no significant difference in T. gondii and N. cani-
num co-infections in the L. chagasi positive or negative
groups (P>0.05).
DISCUSSION
Studies with dogs infected with Leishmania spp. and
associations with other coccidian parasites have been
conducted; however, different results were observed. Co-
infection among these three parasites have been studied
in dogs from Brazil by Gennari et al. (2006) in Araçatuba,
SP, however, the clinical status of the animals relative to
VL was not reported. In the study conducted in Araçatuba,
the prevalence of N. caninum (17.6%) and T. gondii (36.8%)
was higher than the values found in the present study, and
an association between the presence of L. chagasi and N.
caninum antibodies was observed.
Two other studies conducted in Mato Grosso do Sul,
Brazil (Andreotti et al. 2006) and in South of Italy (Cringoli
et al. 2002) observed, respectively, a lack of association
and an association between L. chagasi and N. caninum-
positive dogs. Also in Italy, a description of a single case
of a simultaneous infection with L. infantum and N. cani-
num in a dog with a skin infection was reported. The authors
concluded that the immunosuppressive effect of L. infantum
may have contributed to the development of the N. cani-
num infection; however, based on histological features, the
skin lesions observed were most likely due to Leishmania
(Tarantino et al. 2001).
In the present study, N. caninum seroprevalence was
4.5%, and its occurrence in Leishmania positive (3.3%)
and negative (6.0%) dogs was lower than the values ob-
served in dogs from other regions of Brazil (Gennari et al.
2002, Cañón-Franco et al. 2003, Azevedo et al. 2005,
Andreotti et al. 2006, Gennari et al. 2006), indicating a low
rate of environmental exposure of the dogs in the region to
this agent. Another explanation for the relatively low occur-
rence of anti-N. caninum antibodies is the feeding habits of
the dogs in urban areas, where the diet is mainly based on
commercial food and contact with other sources of animal
products is reduced. Studies have demonstrated signifi-
cant differences in N. caninum occurrence in rural and urban
dogs (Wouda et al. 1999, Fernandes et al. 2004, Wanha et
al. 2005), and between stray and owned animals (Gennari
et al. 2002), with low values for the owned and urban dogs.
The dogs from the present study were captured by the
Zoonosis Control Center, so the majority was stray dogs
with a higher opportunity to acquire the oocysts contami-
nating the environment.
All dogs with anti-N. caninum antibodies had titers of
50, and against T. gondii, the most frequent titer was 128.
In a cross-section study conducted in apparently healthy
dogs from the state of Paraíba, in the northeast region of
Brazil, 50% of the seropositive dogs presented low titers;
however, very high titers were also observed for both
coccidian parasites (Azevedo et al. 2005).
Toxoplasma gondii occurrence was significantly higher
than that of N. caninum in tested dogs from both groups,
which is expected based on observations from other regions
from Brazil (Souza et al. 2002, Souza et al. 2003, Azevedo
et al. 2005, Dubey et al. 2007), reflecting the high exposure
of this host to T. gondii in Brazil and the fact that dogs are
considered good sentinels for T. gondii environmental con-
tamination (Dubey & Beattie 1988).
The co-infection between coccidians in the dogs was
2.0% (1/50), and 3.3% (2/60) of animals were simultaneou-
sly positive for all three parasites. These data were similar
with previous studies, in which co-infection of N. caninum
and T. gondii in dogs varied between 1% and 3% (Lindsay
et al. 1990, Mineo et al. 2001), and was different from the
17.3% observed by Gennari et al. (2006).
The number of dogs positive for N. caninum in each L.
Table 5. Occurrence of antibodies against Neospora
caninum and Toxoplasma gondii in dogs infected
with Leishmania chagasi with different clinical forms
of canine leishmaniasis (n=60) and in non-infected
control dogs (n=50) from the municipality of Santa Luzia,
Minas Gerais, Brazil
Clinical Signs Nº of Dogs Nº of Positive Dogs(%)
(%) N. caninum T. gondii
Asymptomatic 10 (16.7) 0(0.0)a 0(0.0)a
Oligosymptomatic 22 (36.7) 1(4.5)a 7(31.8)a
Symptomatic 28 (46.6) 1(3.6)a 8(28.6)a
Absence 10 (16.7) 0(0.0)a 0(0.0)a
Presence 50 (83.3) 2(2.5)a 15(30.0)b
Total 60 (100.0) 2(3.3)c 15(25.0)d
Control Group 50 (100.0) 3 (6.0)c 21(42.0)d
Total 110 (100,0) 5(4,5) 36(32,7)
Comparisons are between categories in the same column.
a P≥0.05 (Chi-square Test).
b P=0.053 (Fisher Test).
c P=0.657 (Fisher Test).
d P=0.058 (Chi-square Test).
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chagasi clinical group was not significantly different,
suggesting that VL, independently of the clinical form of
disease, does not influence N. caninum infection. When
VL dogs were analyzed as a single group, no association
between Leishmania infection and the presence of antibo-
dies against N. caninum was observed. Similar results were
found in asymptomatic dogs from Campo Grande (Andreotti
et al. 2006). However, Gennari et al. (2006) verified a signi-
ficant association between dogs naturally infected with L.
chagasi and high occurrence of anti-N. caninum antibodies
(8.6 times greater than VL negative dogs). Cringoli et al.
(2002), studying 1,058 asymptomatic dogs from Italy, also
reported the same association and suggested that immu-
nosuppression is likely the cause of the greater prevalen-
ce of N. caninum in Leishmania seropositive dogs.
Toxoplasmosis is a disease usually associated with im-
munosuppressive disorders (Innes 1997). In the present
survey, among dogs infected with L. chagasi, a tendency of
association between infection with T. gondii and presence
of symptoms was verified, suggesting that the clinical form
of canine leishmaniasis seems to enhance susceptibility to
T. gondii. It is expected that the immunodeficiency caused
by Leishmania helped underlying agents and subsequently,
an immune response to these agents was mounted. In
humans, mice (Liew & O’Donnell 1993) and dogs (Cabral et
al. 1992, Pinelli et al. 1994, Pinelli et al. 1995), it was de-
monstrated that protective immunity against leishmaniasis
is mediated by T cells and is associated with the production
of IFN-γ. The ineffectiveness of cellular immunity is a basic
aspect of pathogenesis of the illness and its progression
(Alvar et al. 2004). Due to the ineffectiveness of cellular
immunity in infected dogs, it is likely that dogs with VL that
are manifesting symptoms facilitate the multiplication and
spread of parasites that are primarily controlled by cellular
defenses, such as T. gondii (Denkers & Gazzinelli 1998),
when compared to asymptomatic dogs, in which protective
cellular immunity is present (Cabral et al. 1992, Pinelli et al.
1994, Pinelli et al. 1995).
Some authors have shown that detection of antibodies
indicates presence of the parasite, but antibodies titers are
not correlated with the severity of clinical signs or presen-
tation of the illness in canine VL (Abranches et al. 1991,
Ferrer et al. 1995, Campino 2002). However, in this study,
significant levels of anti-Leishmania antibodies were ob-
served in different clinical groups, with higher titers in symp-
tomatic dogs. Other publications have also noted a
correlation between the levels of immunoglobulin isotypes
and different clinical forms of canine VL (Almeida et al.
2005, Reis et al. 2006b, Costa-Val et al. 2007).
The clinical signs seen in the dogs in this experiment
corroborated the results of the majority of authors (Sla-
ppendel 1988, Ciaramella et al. 1997, Koutinas et al. 2001,
Amusategui et al. 2003, Costa-Val et al. 2007), and de-
monstrated lymphoadenopathy as the most common clini-
cal manifestation of the disease.
Further studies involving different immunological as-
pects of the infection should be developed with dogs infec-
ted with Leishmania, including all clinical forms, to deter-
mine the role of the immune system in co-infection by other
parasites.
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